No abstract available
MeSH terms
-
Administration, Oral
-
Antibodies, Antiphospholipid / blood
-
Anticoagulants / administration & dosage
-
Anticoagulants / therapeutic use*
-
Antiphospholipid Syndrome / blood
-
Antiphospholipid Syndrome / complications
-
Antiphospholipid Syndrome / drug therapy*
-
Factor Xa Inhibitors / administration & dosage
-
Factor Xa Inhibitors / therapeutic use*
-
Humans
-
Lupus Coagulation Inhibitor / blood
-
Meta-Analysis as Topic
-
Prospective Studies
-
Randomized Controlled Trials as Topic
-
Rivaroxaban / administration & dosage
-
Rivaroxaban / therapeutic use*
-
Thromboembolism / etiology
-
Vitamin K / antagonists & inhibitors*
-
Warfarin / administration & dosage
-
Warfarin / therapeutic use*
-
beta 2-Glycoprotein I / blood
Substances
-
Antibodies, Antiphospholipid
-
Anticoagulants
-
Factor Xa Inhibitors
-
Lupus Coagulation Inhibitor
-
beta 2-Glycoprotein I
-
Vitamin K
-
Warfarin
-
Rivaroxaban